Safety of repeated transplantations of neurotrophic factors‐secreting human mesenchymal stromal stem cells
Abstract Background Therapies based on mesenchymal stem cells (MSC) have been shown to have potential benefit in several clinical studies. We have shown that, using a medium‐based approach, MSC can be induced to secrete elevated levels of neurotropic factors, which have been shown to have protective...
Main Authors: | Yael Gothelf, Natalie Abramov, Adrian Harel, Daniel Offen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-12-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/2001-1326-3-21 |
Similar Items
-
miRNA profiling of NurOwn®: mesenchymal stem cells secreting neurotrophic factors
by: Yael Gothelf, et al.
Published: (2017-11-01) -
Role of cryopreserved multipotent mesenchymal stromal cells in modulation of some indices of cell immunity in adjuvant arthritis
by: Dmytro Vvedenskyi, et al.
Published: (2022-07-01) -
Reconstitution and post-thaw storage of cryopreserved human mesenchymal stromal cells: Pitfalls and optimizations for clinically compatible formulants
by: Rasmus Roost Aabling, et al.
Published: (2023-06-01) -
Optimizing cryopreservation conditions for use of fucosylated human mesenchymal stromal cells in anti-inflammatory/immunomodulatory therapeutics
by: Jesús I. Gil-Chinchilla, et al.
Published: (2024-03-01) -
Mesenchymal Stromal Cells for Transplant Tolerance
by: Manuel Alfredo Podestà, et al.
Published: (2019-06-01)